Your browser doesn't support javascript.
loading
Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.
Reardon, David A; Lassman, Andrew B; Schiff, David; Yunus, Shakeeb A; Gerstner, Elizabeth R; Cloughesy, Timothy F; Lee, Eudocia Quant; Gaffey, Sarah C; Barrs, Jennifer; Bruno, Jennifer; Muzikansky, Alona; Duda, Daniel G; Jain, Rakesh K; Wen, Patrick Y.
Affiliation
  • Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lassman AB; Department of Neurology, Columbia University Medical Center, New York, New York.
  • Schiff D; Department of Neurology, University of Virginia Medical Center, Charlottesville, Virginia.
  • Yunus SA; Hematology/Oncology, University of Massachusetts Memorial Medical Center, Worchester, Massachusetts.
  • Gerstner ER; Department of Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Cloughesy TF; Department of Neurology, University of California, Los Angeles, Los Angeles, California.
  • Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gaffey SC; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Barrs J; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Bruno J; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Muzikansky A; Biostatistics, Massachusetts General Hospital, Boston, Massachusetts.
  • Duda DG; Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Jain RK; Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer ; 124(7): 1438-1448, 2018 04 01.
Article in En | MEDLINE | ID: mdl-29266174
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Glioblastoma / Angiopoietins / Neoplasm Recurrence, Local Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Glioblastoma / Angiopoietins / Neoplasm Recurrence, Local Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2018 Type: Article